Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

44.56
-0.4392-0.98%
Post-market: 44.56-0.0038-0.01%19:30 EDT
Volume:9K
Turnover:402.62K
Market Cap:42.34M
PE:- -
High:45.50
Open:45.50
Low:44.26
Close:45.00
52wk High:56.18
52wk Low:27.62
Shares:950.00K
Float Shares:950.00K
Volume Ratio:0.40
T/O Rate:0.95%
Dividend:0.66
Dividend Rate:1.47%
ROE:--
ROA:--
PB:0.96
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Virtus LifeSci Biotech Clinical Trials ETF
Exchange:
ARCA
Establishment Date:
2014
Employees:
- -
Office Location:
One Financial Plaza,26th Floor,Hartford,Connecticut,United States
Website:
- -
Zip Code:
06103
Fax:
860-241-1024
Introduction:
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.